Cargando…
Forward genetic screens identify mechanisms of resistance to small molecule lactate dehydrogenase inhibitors
Altered metabolism is a hallmark of cancer; however, it has been difficult to specifically target metabolism in cancer for therapeutic benefit. Cancers with genetically defined defects in metabolic enzymes constitute a subset of cancers where targeting metabolism is potentially accessible. Hürthle c...
Autores principales: | Frank, Anderson R, Vandiver, Florentina, McFadden, David G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557759/ https://www.ncbi.nlm.nih.gov/pubmed/37808702 http://dx.doi.org/10.1101/2023.09.30.560315 |
Ejemplares similares
-
Natural compounds as lactate dehydrogenase inhibitors: potential therapeutics for lactate dehydrogenase inhibitors-related diseases
por: Han, Jung Ho, et al.
Publicado: (2023) -
Virtual screening, identification and in vitro validation of small molecule GDP-mannose dehydrogenase inhibitors
por: Dolan, Jonathan P., et al.
Publicado: (2023) -
A novel small-molecule inhibitor of 3-phosphoglycerate dehydrogenase
por: Mullarky, Edouard, et al.
Publicado: (2016) -
Synthesis and initial screening of lactate dehydrogenase inhibitor activity of 1,3-benzodioxole derivatives
por: Annas, Dicky, et al.
Publicado: (2020) -
Preparation
of a Mesoporous Biosensor for Human Lactate
Dehydrogenase for Potential Anticancer Inhibitor Screening
por: Cocuzza, Clarissa, et al.
Publicado: (2023)